news.cision.com

Recipharm, a global contract development and manufacturing organization (CDMO), has announced today that its subsidiary, GenIbet Biopharmaceuticals, has been approved by the US Food and Drug Administration (FDA) as a manufacturing site of VOWST, a breakthrough orally administered fecal microbiota product for the prevention of Clostridioides difficile recurrent infection (CDI) in adults following antibacterial treatment for recurrent CDI. Recipharm will manufacture VOWST at its GenIbet site in Oeiras, Portugal on behalf of Seres Therapeutics. In the US, CDI has been classified as one

Klimator contracts one of the largest municipalities in Denmark for smart decision-making solutions for winter road maintenance

Klimator has signed a contract with one of the largest municipalities in Denmark for a full suite of road weather stations and monitoring software for making call-out decisions on road and bicycle lanes. The total order value for the first year is approx. 600 KSEK.The deal is the first one for this size of municipality and establishes Klimator as a supplier across all sizes and types of organisations. “We are happy to expand our solutions to more and more customers, also seeing larger organisations joining the list. There is a need to focus on cost reductions, but also the

Semcon’s sustainability report 2022

Semcon's sustainability report for 2022 is now published on the company's website.During 2022, Semcon continued to grow its operations with high profitability. The sustainability offering was further strengthened, among other things through the acquisition of the sustainability consulting company Goodpoint. “Many of our customer projects support the transition to a sustainable society. But change needs to be faster. At Semcon, we work decisively with our internal sustainability agenda, but our biggest contribution is through our customer projects. With Semcon’s unique offering, we see

Sitowise Group Plc issues 37,330 own shares in a directed issue relating to acquisition of Infrasuunnittelu Oy

Tue, May 02, 2023 11:05 CET

Sitowise Group Plc Changes in company's own shares 2 May 2023 at 12.30 pm EEST The Board of Directors of Sitowise Group Plc (“Sitowise”) has decided on 2 May 2023, by virtue of the authorization granted by the annual general meeting on 25 April 2023, to issue 37,330 own shares (the "Share") held by Sitowise in a directed share issue. The number of Shares to be subscribed for in the share issue (the “Share Issue”) corresponds to approximately 0.10 per cent of shares in Sitowise. The Share Issue relates to an acquisition of all shares in

Pharmacolog’s chairman of the board leaves his position at his own request

Pharmacolog i Uppsala AB (publ) announces that Björn Varnestig requests to be dismissed from his position as chairman of the board with immediate effect due to personal reasons.The company has initiated the process to find a new chairman of the board.

Resqunit AB - Annual Report 2022

Correction:[This correction is published because the MAR label should not have been included in the previous message]Resqunit AB (publ) ("Resqunit") May 2nd, 2023, at 11.00 CET.2022 compared to 2021 Group revenue have been limited in both yearsOperating profit amounted to -9 324 973 SEK (-11 607 054 SEK)Earnings per share -0,86 SEK (-1,10 SEK) Key figures (SEK) 2022 Group 2021 Group Proforma Unaudited UnauditedNet sales 340 322 66 918Operating profit

Director/PDMR Shareholding

2 May 2023 10:00 BST Transaction by Person Discharging Managerial Responsibilities AstraZeneca PLC (the Company) announces that Michel Demaré, Non-Executive Chair of the Board, purchased 2,000 of the Company's ordinary shares of $0.25 each (Ordinary Shares) on 28 April 2023. Further details are set out in the attached notification, made in accordance with the requirements of the EU Market Abuse Regulation (since it forms part of UK law pursuant to the European Union (Withdrawal) Act 2018). 1 Details of the person discharging managerial responsibilities / person

Alma Finanssipalvelut Oy now licensed to carry out payment intermediation

Alma Media Corporation Press Release 2 May 2023ALMA FINANSSIPALVELUT OY NOW LICENSED TO CARRY OUT PAYMENT INTERMEDIATION Alma Media's Alma Finanssipalvelut Oy has been granted a licence to carry out payment intermediation in accordance with the Payment Institutions Act, which can be used, for example, in vehicle trade between consumers. The licence has been granted by the Financial Supervisory Authority. Until now, in Alma Media services, payment intermediation has been provided by partners. “Payment intermediation will support Alma Media's marketplace business,

Quickbit announces change to Group Management

Today, Quickbit announces that Sneha Patel, Head of Finance, is leaving Quickbit to take on new challenges. At the same time, Daniel Boettge has been appointed as new interim CFO. As of today, May 2, 2023, Daniel replaces Sneha in the Group Management Team.Daniel has a degree in business and law from Stockholm University. He has a lot of experience in finance, accounting and law. Daniel has 15+ years of experience in accounting, organizational development, tax and corporate law. “I want to thank Sneha for her work, professionalism and commitment here at Quickbit. At the same time, I

SAS OPENS NEW ROUTE TO BANGKOK

SAS is continuing to strengthen its offer and to accommodate an increased demand for leisure travel, SAS will now open a new route to Bangkok, Thailand. Following this route expansion travelers will be able to fly direct to Bangkok three times weekly with convenient overnight flights in both directions using the Airbus A350 aircraft.First departure is planned from Copenhagen on the 30[th] of October 2023. “Thailand and the Scandinavian countries have a long history of friendship and cooperation and returning with a direct route after nine years is a true pleasure. The Bangkok route will

Saab’s Giraffe 1X wins UK Ministry of Defence orders

Tue, May 02, 2023 10:57 CET

Saab has signed two contracts for eleven Giraffe 1X radars including support with the UK’s Ministry of Defence. The total order value is approximately SEK 264 million and deliveries have already started.The acquisition of Giraffe 1X is largely for operational environments, whilst a single unit has been procured by the Royal Navy and will be mounted and tested on the XV Patrick Blackett. This ship is operated by NavyX to test, trial and experiment with new technologies and concepts. Giraffe 1X is a lightweight, multi-mission, 3D surveillance radar for simultaneous air- and surface

(Reminder) Invitation to Kongsberg Automotive's Q1 2023 Earnings Presentation

Zurich, May 2, 2023: Kongsberg Automotive (KA) will release its Q1 results on Tuesday, May 09, 2023 at approximately 07:00 CET. President & CEO Joerg Buchheim and CFO Frank Heffter will present the results during a webcast at 08:00 CET and will host a Q&A session after the presentation. The event is open to the public and will be webcasted live. The following link https://channel.royalcast.com/landingpage/hegnarmedia/20230509_7/

BioStock: Xintela initiates last dose level in knee osteoarthritis study

Tue, May 02, 2023 10:55 CET

Xintela recently announced that they have initiated the third and last dose level in the phase I/IIa study with the stem cell product XSTEM in patients with knee osteoarthritis. The company’s goal is to present safety data from all dose levels and early efficacy results in 2023. BioStock contacted Camilla Wennersten, Director Clinical Development at Xintela, to find out more about the study.Read the full article at biostock.se: https://www.biostock.se/en/2023/05/xintela-initiates-last-dose-level-in-knee-osteoarthritis-study/ This is a press release from BioStock - Connecting

Herantis Pharma to participate in Bio€quity Europe 2023 in Dublin May 2023

Tue, May 02, 2023 10:45 CET

Herantis Pharma Plc, Press Release, 2 May 2023 at 11:45 A.M. EEST Herantis Pharma Plc (“Herantis”), a clinical-stage biotechnology company developing disease modifying therapies for Parkinson’s disease, today announced that Herantis Pharma has been selected as presenting company with live presentation during the 23rd Bio€quity Europe Conference, in May 14-16, 2023 in Dublin. CEO, Antti Vuolanto will give a company presentation: May 16[th] at 11:39 AM EEST / 10:39 AM CET / 09:39 AM IST Location: Liffey Meeting Room 3, Convention Centre Dublin If you want 1x1 meetings with

Citycon signed total EUR 650 million committed syndicated credit facility

Tue, May 02, 2023 10:40 CET

CITYCON OYJ Investor News 2 May 2023 at 11.40 hrsCitycon Oyj has signed total EUR 650 million new committed syndicated multicurrency credit facility, to replace and extend its existing EUR 500 million facilities maturing in May 2024. The new facility consists of EUR 400 million revolving credit facility and a EUR 250 million term loan, and is fully secured by Iso Omena and four Norwegian assets.The credit facilities can be used for general corporate purposes. The maturity of both new facilities is 3 years, with one year extension option (3+1 years). The margin of the facilities is

Corporate and Operational Update

Tue, May 02, 2023 10:31 CET

2 May 2023 IOG plc Corporate and Operational Update IOG plc ("IOG", or "the Company"), (AIM: IOG.L) provides a corporate and operational update ahead of its Annual General Meeting which is being held at 10.00am this morning. An accompanying presentation is available at the IOG website and can be accessed via this link: https://bit.ly/3LuKbPW Highlights · Blythe H1 producing steadily at 17 mmscf/d gross rate, averaging 14.9 mmscf/d year to date o 95.4% Operating Efficiency and 86.4% Production Efficiency · Steady progress towards resolution of Blythe H2 drilling

Solteq Plc: Solteq and Azets have completed the business transfer – Solteq’s Microsoft BC and LS Retail based ERP business transferred to Azets

Press ReleaseMay 2, 2023, at 11:30 a.m. (EET) The transaction, whereby Solteq’s ERP business based on Microsoft Dynamics 365 Business Central and LS Retail solutions were sold to Azets, has been completed today. The company announced the signing of the business transfer agreement on April 17, 2023. The transferring business consisted of the clientele related to Solteq’s Microsoft Dynamics 365 Business Central and LS Retail ERP solutions and approximately 60 experts located in Finland, Sweden, Norway, and Denmark. The fixed purchase price of the business is EUR 15

Qred proposes Caroline Farberger as new board member

Stockholm, May 2, 2023 - Qred proposes Caroline Farberger as a new board member ahead of the Annual General Meeting on May 30, 2023. Qred, the fastest growing fintech company in Sweden according to the Financial Times, is the leading financing platform for small businesses in 6 markets in the Nordics and Benelux. Now Caroline Farberger is elected to the board. Caroline Farberger has more than 25 years of experience from the financial industry, including from ICA, where she started and built the group's insurance operations. In addition to this, Caroline has extensive

Rutger Arnhult appointed new CEO of Corem

The Board of Directors of Corem has appointed Rutger Arnhult as CEO of the company, effective from 16 June 2023. Rutger succeeds Eva Landén who will assume the role as Executive Vice President. Corem’s core business has developed steadily over the past year through continued activity in property management and lettings operations. At the same time, divestments and debt repayments have been priorities in order to strengthen the balance sheet, focusing on securing long-term, resilient finances. Rutger Arnhult’s appointment as CEO reflects a continued focus on strengthening the balance

Start of Dicot's phase 1 trial booked for August